Clinical Trials on TUBB4A-Related Leukodystrophy

Total 51608 results

Pear Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Kaiser Foundation Research Institute; Whitman-Walker Institute, Inc... and other collaborators

Completed

Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence

Opioid Use Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

Opioid Use Disorder

United States
Trevi Therapeutics
Syneos Health

Completed

Oral Abuse Potential Study of Nalbuphine

Opioid Abuse | Nalbuphine

Canada
Braeburn Pharmaceuticals

Completed

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

Opioid Use Disorder

United States, United Kingdom, Taiwan, Hungary, Australia, Denmark, Germany, Sweden
Cambridge Health Alliance
Dartmouth College; MedicaSafe, Inc.; MySafeRx, Inc

Completed

MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Interactions Between Cocaine and Ethanol and Disulfiram - 1

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Role of Instructions in Nitrous Oxide Effects and Choice - 10

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Isoflurane at Subanesthetic Concentrations - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Nitrous Oxide: A Dose-Response Analysis - 5

Substance-Related Disorders | Opioid-Related Disorders

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...

Completed

Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects

Alcoholism | Alcohol Related Disorders | Alcohol Abuse

United States
University of Pittsburgh

Completed

Quantitative Sensory Psychophysical Correlates of Pain in Pregnant Women With OUD (Q-PRONTO)

Pregnancy Related | Opioid-use Disorder

United States
VA Office of Research and Development

Completed

sTMS for Substance Use-disordered Veterans

Alcohol Addiction | Opioid Addiction | Cocaine Addiction

United States
University of Delaware
National Institute on Drug Abuse (NIDA); Brandywine Counseling and Community...

Recruiting

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Opioid Use Disorder

United States
Brigham and Women's Hospital
University of Utah

Not yet recruiting

Extended-release Buprenorphine as a Novel Low-dose Induction Strategy

Opioid Use Disorder
Butler Hospital
National Institute on Drug Abuse (NIDA)

Recruiting

tDCS to Decrease Opioid Relapse (UH3)

Opioid Use Disorder

United States
Prisma Health-Upstate
National Institute on Drug Abuse (NIDA); Clemson University

Recruiting

Development, Refinement, and Validation of a Peer Support Specialist Checklist for Individuals With Opioid Use Disorder / STAMPS: South Carolina Buprenorphine Treatment Initiation, Adherence, and Retention Utilizing Mobile Health Units and Peer Support Specialists

Opioid Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Friends Research Institute, Inc.

Not yet recruiting

Buprenorphine for Individuals in Jail

Opioid Use Disorder

United States
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Recruiting

A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Assessing Optimal XRB Initiation Points in Jail

Opioid Use Disorder

United States
University Hospital, Strasbourg, France

Recruiting

Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach (BEBOP)

Opioid Use Disorder

France
Philadelphia College of Osteopathic Medicine
Prevention Point Philadelphia

Recruiting

Cognitive-Behavioral Therapy for Opioid Use Disorder: A Manualized Pilot Study

Opioid Use Disorder

United States
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
Pouya Azar

Recruiting

Symptom-inhibited Fentanyl Induction (SIFI)

Opioid Use Disorder

Canada
University of Kentucky
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Cannabis and Opioid Use Disorder

Opioid Use Disorder
Region Skane
Lund University

Not yet recruiting

Effects on Mortality and Clinical Course of a Patient's Choice Model for Opioid Maintenance Treatment for Opioid Dependence - Evaluation of a System Enabling a Large Expansion of Treatment Providers and Treatment Access

Opioid Dependence | Overdose

Sweden
Gazi University

Recruiting

Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process

Opioid Use Disorder

Turkey
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Aptinyx

Recruiting

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

Opioid Use Disorder

United States
VA Office of Research and Development

Recruiting

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder (VA-BRAVE)

Opioid Use Disorder

United States
University of British Columbia

Recruiting

Computerized Exercise to Alter Stimulant Approach Responses (CEASAR)

Substance-Related Disorders | Cocaine-Related Disorders | Amphetamine-Related Disorders

Canada
AstraZeneca

Completed

A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.

Opioid Use Disorder

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

tDCS to Decrease Opioid Relapse (UG3)

Opioid Dependence | Craving

United States
Center for Social Innovation, Massachusetts
West Haven VA

Completed

Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (OASIS)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
3D Therapy, LLC

Completed

The Feasibility of VR for OUD

Opioid Use Disorder

United States
Johns Hopkins University

Withdrawn

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

Opioid Use Disorder
Real Prevention, LLC
University of Missouri-Columbia

Completed

Reducing High School Athletes' Prescription Opioids Misuse and Diversion Through the Student Athlete Wellness Portal

Prescription Opioid Misuse

United States
VA Office of Research and Development

Completed

Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services

Alcoholism | Dual Diagnosis | Substance-related Disorders

United States
Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
Carilion Clinic

Completed

START NOW in the Treatment of Opioid Addicted Individuals

Opioid Use Disorder

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Terminated

A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders

Opioid Use Disorder

United States
Butler Hospital

Withdrawn

Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment

Opioid Use Disorder

United States
Novartis Pharmaceuticals

Completed

Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

Cocaine-related Disorder

Spain, Argentina, Switzerland

Clinical Trials on TUBB4A-Related Leukodystrophy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations